NXTC

Conviction 18HealthcareScan · Mon, Aug 10, 2026

Rising three methods

NXTC$6.80+16.44%

ResistanceSupportVol 14

Vol MA14 424.87K

May 11May 28Jun 16Jul 6Jul 23Aug 10

NextCure, Inc.PHARMACEUTICAL PREPARATIONSwww.nextcure.com ↗

Price6.80

Change+16.44%

Gap+8.30%

Rel volume0.05×

Avg volume6.44M

Avg $ vol41.71M

SMA 205.35

SMA 503.54

SMA 2009.38

Price vs 50+92.35%

Price vs 200-27.54%

MA stackmixed

50/200 cross—

Supertrenddown · 7.08

RSI (14)65

MACD hist0.14

MACD crossbull · 4d

Stoch %K / %D89 / 85

ADX (14)41

+DI / −DI39 / 13

RSI divergence—

MACD divergence—

ATR %+14.37%

ADR %19.88%

52w high14.27

52w low1.60

From 52w high-52.35%

Above 52w low+325.00%

New 52w highNo

SqueezeOff

Bollinger width60.26%

%B0.95

Donchian pos47.90%

Donchian high9.90

Donchian low3.95

AVWAP (52w high)7.23

vs AVWAP high-5.96%

AVWAP (52w low)7.15

vs AVWAP low-4.86%

OBV trendUp

Chaikin MF (20)-0.51

Today vs 20d0.05×

Avg vol (14d)424.87K

Avg vol (20d)6.44M

Avg $ vol (20d)41.71M

Market cap31.13M

RS 3m (vs SPY)-48.33%

RS 6m (vs SPY)-61.45%

RS line new highNo

Trend template2/8

Technical rank43.6

1 week+54.55%

1 month+245.18%

3 months-30.33%

6 months-38.74%

1 year+33.46%

YTD-48.80%

P/E-0.56

P/B2.56

P/S1.39

P/FCF-0.62

EPS-19.65

Div yield—

ROE-459.66%

ROA-246.88%

Debt/Eq0.22

Current3.47

EV/EBITDA-0.33

Gross margin—

Net margin-249.55%

Rev growth0.00%

EPS growth-0.34%

Price target20.00

Target upside194.12%

Analyst ratingBuy

Institutional46.31%

Ent. value18.51M

Revenue22.38M

Net income-14.89M

Gross profit—

Free cash flow-50.09M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out3.61M

Employees40

ListedThu, May 9, 2019

Free float2.51M

Float %69.7%

Short interest1.32M

Days to cover0.1d

Short volume52.3%

Squeeze score49 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.84 vs −$1.98

Last surprise+7.1% beat

Setup gradeD

Conviction18 / 100

Pattern quality—

Tech rank43.6 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmRising three methods

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NXTC

All disclosures →

No recent disclosed trades by Congress in NXTC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NXTC · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Borgman Anne Elizabeth Director · Stock Option (Right to Buy) · 2026-06-18	Grant	2.34K	—	2026-06-18	2026-06-22
Houston John G Director · Stock Option (Right to Buy) · 2026-06-18	Grant	2.34K	—	2026-06-18	2026-06-22
Webster Stephen W Director · Stock Option (Right to Buy) · 2026-06-18	Grant	2.34K	—	2026-06-18	2026-06-22
Feigal Ellen Director · Stock Option (Right to Buy) · 2026-06-18	Grant	2.34K	—	2026-06-18	2026-06-22
Jones Elaine V Director · Stock Option (Right to Buy) · 2026-06-18	Grant	2.34K	—	2026-06-18	2026-06-22
KABAKOFF DAVID S Director · Stock Option (Right to Buy) · 2026-06-18	Grant	3.51K	—	2026-06-18	2026-06-22

SEC filings

EDGAR filings in NXTC · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.